BMY

Bristol-Myers Squibb

Halal Rating :
Comfortable
Last Price $56.5 Last updated:
Market Cap $101.27b
7D Change

1.97 %

1 Year Change

13.88 %

Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange NYSE
Next Earnings Date Oct. 31, 2024

Bristol-Myers Squibb Company (BMY) is a biopharmaceutical company that discovers, develops, and delivers innovative medicines to help patients prevail over serious diseases. The company focuses on oncology, hematology, immunology, and cardiovascular disease. Their portfolio includes several leading pharmaceutical products such as Eliquis, Opdivo, and Revlimid.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $11.89b $9.98b - - 0.00% 0.00%
June 30, 2024 $12.2b $10.64b - - 0.00% 0.00%
March 31, 2024 $11.87b $23.3b - - 0.00% 0.00%

Company Impact

Help us evaluate Bristol-Myers Squibb's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates